$BOMO
bowmo, Inc. Stock $bomo

$bomo Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-K Financial Statement

#000121390024086614 Filed on October 09, 2024

Income Statement

Concept	2024 Q4	2023 Q4	2023
Revenue		$177.0K	$243.4K
YoY Change		390.47%	30.93%
Cost Of Revenue		$200.0K	$200.0K
YoY Change		630.07%	163.65%
Gross Profit		-$23.08K	$43.40K
YoY Change		-365.9%	-60.57%
Gross Profit Margin		-13.04%	17.83%
Selling, General & Admin		$127.1K	$990.0K
YoY Change		-86.8%	-43.68%
% of Gross Profit			2281.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$127.1K	$990.0K
YoY Change		-86.8%	-43.68%
Operating Profit		-$150.2K	-$946.6K
YoY Change		-84.26%	-40.84%
Interest Expense		-$1.953M	-$2.802M
YoY Change		-28.07%	-402.28%
% of Operating Profit
Other Income/Expense, Net			-$2.802M
YoY Change			-4.44%
Pretax Income		-$2.103M	-$3.749M
YoY Change		-42.68%	-18.15%
Income Tax
% Of Pretax Income
Net Earnings		-$2.103M	-$3.749M
YoY Change		-42.68%	-18.5%
Net Earnings / Revenue		-1188.65%	-1540.03%
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.11
COMMON SHARES
Basic Shares Outstanding	136.5M shares	40.76M shares	18.98M shares
Diluted Shares Outstanding			18.98M shares

Balance Sheet

Concept	2024 Q4	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$6.310K
YoY Change		-96.22%
Cash & Equivalents		$6.308K
Short-Term Investments
Other Short-Term Assets		$1.840K
YoY Change		113.95%
Inventory
Prepaid Expenses
Receivables		$18.17K
Other Receivables		$0.00
Total Short-Term Assets		$26.32K
YoY Change		-85.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets		$26.32K
Total Long-Term Assets		$0.00
Total Assets		$26.32K
YoY Change		-85.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.145M
YoY Change		40.74%
Accrued Expenses		$213.7K
YoY Change		-41.71%
Deferred Revenue
YoY Change
Short-Term Debt		$470.1K
YoY Change		-29.79%
Long-Term Debt Due		$254.5K
YoY Change		-16.15%
Total Short-Term Liabilities		$4.472M
YoY Change		-23.16%
LONG-TERM LIABILITIES
Long-Term Debt		$193.2K
YoY Change		-25.83%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$193.2K
YoY Change		-25.83%
TOTAL LIABILITIES
Total Short-Term Liabilities		$4.472M
Total Long-Term Liabilities		$193.2K
Total Liabilities		$4.665M
YoY Change		-23.28%
SHAREHOLDERS EQUITY
Retained Earnings		-$12.99M
YoY Change		40.56%
Common Stock		$535.00
YoY Change		-99.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$773.5K
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity		-$4.639M
YoY Change
Total Liabilities & Shareholders Equity		$26.32K
YoY Change		-85.66%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.103M	-$3.749M
YoY Change	-42.68%	-18.5%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$4.396M	-$4.531M
YoY Change	2152.78%	633.66%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.277M
YoY Change		2085.53%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.398M	$4.370M
YoY Change	1556.52%	458.72%
NET CHANGE
Cash From Operating Activities	-4.396M	-$4.531M
Cash From Investing Activities	0.000
Cash From Financing Activities	4.398M	$4.370M
Net Change In Cash	2.440K	-$160.8K
YoY Change	-96.61%	-196.45%
FREE CASH FLOW
Cash From Operating Activities	-$4.396M	-$4.531M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54624
CY2023	dei	Entity Registrant Name EntityRegistrantName	BOWMO, INC.
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	99 Wall Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 891
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10005
CY2023	dei	City Area Code CityAreaCode	(212)
CY2023	dei	Local Phone Number LocalPhoneNumber	398-0002
CY2023	dei	Security12g Title Security12gTitle	common stock, par value $0.0001 per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	13645	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	136458010	shares
CY2023	dei	Auditor Name AuditorName	Olayinka Oyebola
CY2023	dei	Auditor Location AuditorLocation	Lagos, Nigeria
CY2023	dei	Auditor Firm AuditorFirmId	5968
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6308	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	167103	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18172	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15542	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1838	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	858	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	26318	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	183503	usd
CY2023Q4	us-gaap	Assets Assets	26318	usd
CY2022Q4	us-gaap	Assets Assets	183503	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1144755	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	813378	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	213697	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	200286	usd
CY2023Q4	bomo	Accrued Interest Current AccruedInterestCurrent	364598	usd
CY2022Q4	bomo	Accrued Interest Current AccruedInterestCurrent	366622	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1384499	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1074361	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	30000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	113006	usd
CY2023Q4	bomo	Loan Payable Related Party LoanPayableRelatedParty	254500	usd
CY2022Q4	bomo	Loan Payable Related Party LoanPayableRelatedParty	190500	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	440109	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	669581	usd
CY2023Q4	bomo	Preferred Stocks Redemption Premium PreferredStocksRedemptionPremium	205684	usd
CY2022Q4	bomo	Preferred Stocks Redemption Premium PreferredStocksRedemptionPremium	219687	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	433818	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2172250	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4471660	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5819671	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	193202	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	260494	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4664862	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6080165	usd
CY2023Q4	bomo	Treasury Stock Share TreasuryStockShare	2917	shares
CY2022Q4	bomo	Treasury Stock Share TreasuryStockShare	0	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	773500	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	773500	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12992877	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9243925	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4638544	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5896662	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26318	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	183503	usd
CY2023	us-gaap	Revenues Revenues	243434	usd
CY2022	us-gaap	Revenues Revenues	185923	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	200039	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	75873	usd
CY2023	us-gaap	Gross Profit GrossProfit	43395	usd
CY2022	us-gaap	Gross Profit GrossProfit	110050	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	517618	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	432452	usd
CY2023	bomo	Consulting Expense ConsultingExpense	90000	usd
CY2022	bomo	Consulting Expense ConsultingExpense	181667	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	250770	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	780251	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	131590	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	363522	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	989978	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1757892	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-946583	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1647842	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	666814	usd
CY2022	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	927072	usd
CY2022	bomo	Gain On New Methodology For Accounting For Debt Conversion Features GainOnNewMethodologyForAccountingForDebtConversionFeatures	27856	usd
CY2023	bomo	Initial Recognition Of Derivative Liability InitialRecognitionOfDerivativeLiability	32429	usd
CY2022	bomo	Initial Recognition Of Derivative Liability InitialRecognitionOfDerivativeLiability	2578230	usd
CY2023	bomo	Fair Value Adjustment Of Derivative Liability FairValueAdjustmentOfDerivativeLiability	2103126	usd
CY2022	bomo	Fair Value Adjustment Of Derivative Liability FairValueAdjustmentOfDerivativeLiability	-544850	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2802369	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2932596	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3748952	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4580438	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3748952	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4580438	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-842293	usd
CY2022	bomo	Stock Issued During Period Value Recapitalization At Reverse StockIssuedDuringPeriodValueRecapitalizationAtReverse	3082418	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4719	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	257500	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	596927	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2264341	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4580438	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5896662	usd
CY2023	bomo	Stock Issued During Period Value Effects Of Reversesplit StockIssuedDuringPeriodValueEffectsOfReversesplit	0	usd
CY2023	bomo	Stock Issued During Period Value Effects Of Forward Split StockIssuedDuringPeriodValueEffectsOfForwardSplit	0	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5007080	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3748952	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4638544	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3748952	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4580438	usd
CY2022	bomo	Reconciliation Of Debt Balances ReconciliationOfDebtBalances	145717	usd
CY2022	bomo	Loss On Acquisition Related Party LossOnAcquisitionRelatedParty	197370	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	321531	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	289252	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	216186	usd
CY2022	bomo	Gain On New Methodology For Accounting For Debt Conversion Features GainOnNewMethodologyForAccountingForDebtConversionFeatures	27856	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14003	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-117565	usd
CY2022	bomo	Initial Derivative Expense InitialDerivativeExpense	2578230	usd
CY2023	bomo	Fair Value Adjustment Of Derivatives Liability FairValueAdjustmentOfDerivativesLiability	-1738432	usd
CY2022	bomo	Fair Value Adjustment Of Derivatives Liability FairValueAdjustmentOfDerivativesLiability	-544850	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2630	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22098	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	980	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-139	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	331080	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	421125	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	11673	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	483915	usd
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	310138	usd
CY2022	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	67123	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3108	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4530575	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-617532	usd
CY2022	bomo	Cash Acquired In Reverse Merger CashAcquiredInReverseMerger	517	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	1633	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2150	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	269100	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	521679	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	770500	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5277042	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	1428941	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	257500	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4369780	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	782100	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-160795	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	166718	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167103	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	385	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6308	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167103	usd
CY2023	bomo	Common Stock Issued For Extinguishment Of Debt And Accrued Interest CommonStockIssuedForExtinguishmentOfDebtAndAccruedInterest	279002	usd
CY2022	bomo	Common Stock Issued For Extinguishment Of Debt And Accrued Interest CommonStockIssuedForExtinguishmentOfDebtAndAccruedInterest	1905322	usd
CY2022	bomo	Tangible Assets Acquired In Merger TangibleAssetsAcquiredInMerger	3082419	usd
CY2022	bomo	Equity Acquired In Merger Net Of Cancellation Of Shares EquityAcquiredInMergerNetOfCancellationOfShares	3063589	usd
CY2022	bomo	Debt Discount Associated With Issuance Of Warrants And Derivative Liabilities DebtDiscountAssociatedWithIssuanceOfWarrantsAndDerivativeLiabilities	734853	usd
CY2023	bomo	Put Premium On Stock Settled Debt Extinguishment PutPremiumOnStockSettledDebtExtinguishment	205684	usd
CY2022	bomo	Put Premium On Stock Settled Debt Extinguishment PutPremiumOnStockSettledDebtExtinguishment	241454	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	1000	usd
CY2022	bomo	Accrual For Shares To Be Issued For Acquisition Of Interview Mastery AccrualForSharesToBeIssuedForAcquisitionOfInterviewMastery	200000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">NOTE 1 – BACKGROUND</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Reverse Merger and Corporate Restructure</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 4, 2022, Cruzani, Inc. (“Cruzani” or the “Predecessor”) entered into a merger agreement (the “Merger Agreement”) with Bowmo, Inc. (“Bowmo”) and Bowmo Merger Sub, Inc. to acquire Bowmo. (the “Acquisition”). The transactions contemplated by the Merger Agreement were consummated on May 4, 2022, and pursuant to the terms of the Merger Agreement, all outstanding shares of Bowmo were exchanged for shares of Cruzani’s common stock and Bowmo became Cruzani’s wholly owned subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The merger was effected pursuant to the Merger Agreement. The merger is being accounted for as a reverse merger whereby Bowmo is the acquirer for accounting purposes. Bowmo is considered the acquiring company for accounting purposes as upon completion of the Merger, Bowmo’s former stockholders held a majority of the voting interest of the combined company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the merger, the Company issued Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders. Upon completion of the acquisition, Bowmo is treated as the surviving entity and accounting acquirer although Cruzani was the legal acquirer. Accordingly, the historical financial statements are those of Bowmo.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Accounting for Reverse Merger</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of Cruzani assets acquired and liabilities assumed was based upon management’s estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the allocation of purchase price of the acquisition: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; font-style: italic">Tangible Assets Acquired:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Allocation</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">517</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(326,400</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,197,027</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued officer compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(453,333</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Convertible Notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(620,933</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Put premium on stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(230,743</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loans payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(254,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Tangible Assets Acquired</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(3,082,419</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left">Equity Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(33,815</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series E Preferred stock to be issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(166,331</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Common stock 20,000,000,000 shares authorized, $0.00001 par value; 8,955,014,498 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(89,550</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Treasury stock, at cost – 2,917 shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">773,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additional paid in capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,648,676</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic">Consideration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Organization and Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bowmo, Inc. (FKA Cruzani, Inc.) (the “Company”) is an AI-powered recruiting platform. The Company’s principal lines of business are direct placement of candidates with employers and Recruiting as a Service which allows the Company’s customers to outsource the management of their recruiting process to the Company. The Company offers recruiting software and services through an online AI-driven platform to connect potential candidates to employers for all businesses looking to address hiring needs. The Company was incorporated as a Delaware corporation in 2016.</p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3748952	usd
CY2023	bomo	Interest Expense And Derivative Liabilities InterestExpenseAndDerivativeLiabilities	947000	usd
CY2023Q4	bomo	Working Capital Deficit WorkingCapitalDeficit	3750722	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12992877	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6308	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	167103	usd
CY2023	us-gaap	Revenues Revenues	243434	usd
CY2022	us-gaap	Revenues Revenues	185923	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentrations of credit risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments which potentially subject the Company to credit risks consist primarily of cash and cash equivalents, and accounts receivable. Cash and cash equivalents are held in United States financial institutions. At times such amounts may exceed federally insured limits.</p>
CY2023	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	27856	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	58092	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	198982	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	216367	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-4595717	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-287779	usd
CY2021	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.02
CY2021	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.02
CY2023Q4	us-gaap	Loans Payable LoansPayable	254500	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	564000	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	646679	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1197681	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	206570	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	528100	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	440109	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	669581	usd
CY2021Q4	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	331600	usd
CY2021Q4	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11000	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	145551	usd
CY2022	bomo	Gain On New Methodology For Accounting For Debt Conversion Features GainOnNewMethodologyForAccountingForDebtConversionFeatures	27856	usd
CY2021Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	110992	usd
CY2022	bomo	Change Due To Issuances ChangeDueToIssuances	-2718645	usd
CY2022	bomo	Derivative Liability Transfer To Put Premium DerivativeLiabilityTransferToPutPremium	-112537	usd
CY2022	bomo	Derivative Gain Loss On Derivative Fair Value DerivativeGainLossOnDerivativeFairValue	-544850	usd
CY2022Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	2172250	usd
CY2023	bomo	Change Due To Issuances ChangeDueToIssuances	4035300	usd
CY2023	bomo	Derivative Liability Transfer To Put Premium DerivativeLiabilityTransferToPutPremium	651156	usd
CY2023	bomo	Derivative Gain Loss On Derivative Fair Value DerivativeGainLossOnDerivativeFairValue	1645712	usd
CY2023Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	433818	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	38771	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	30842	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	4167	usd
CY2023Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	150000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	50000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	197370	usd
CY2019Q3	us-gaap	Salaries And Wages SalariesAndWages	10000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	120000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022	bomo	Stock Issued During Period Extinguishment Of Convertible Debt StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt	18094721962	usd
CY2023	bomo	Stock Issued During Period Extinguishment Of Convertible Debt StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt	6364768689	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53520830	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27049736	shares
CY2023	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1,000 to 1
CY2023	bomo	Stock Issued During Period Shares Post Reverse Split StockIssuedDuringPeriodSharesPostReverseSplit	250000	shares
CY2022	bomo	Stock Issued During Period Shares Post Reverse Split StockIssuedDuringPeriodSharesPostReverseSplit	250000	shares
CY2022	bomo	Class Of Warrants Or Rights Warrants Issued During Period ClassOfWarrantsOrRightsWarrantsIssuedDuringPeriod	5616000000	shares
CY2022	bomo	Warrant To Purchase Common Shares WarrantToPurchaseCommonShares	5616000000	shares
CY2023	bomo	Additional Warrants To Purchase AdditionalWarrantsToPurchase	7500000	shares
CY2023	bomo	Fair Value Of Warrants FairValueOfWarrants	596927	usd
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.00025
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	0.0025
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	13116000000000	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	500	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	50
CY2023	bomo	Increased Decrease Indebtedness IncreasedDecreaseIndebtedness	1200000	usd
CY2017Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	27084	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	12992877	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9243925	usd
CY2023	bomo	Percentage Of Annual Utilization Of Current Year Income Percentage PercentageOfAnnualUtilizationOfCurrentYearIncomePercentage	0.80	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3361000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2923000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	517618	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	245000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	192697	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	193000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4071315	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3361000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4071315	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3361000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1529	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1529	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.025	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.025	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3879	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3879	pure
CY2023	bomo	Percentage Of Minimum Change In Ownership PercentageOfMinimumChangeInOwnership	0.50	pure
CY2020Q1	bomo	Coronavirus Aid Relief And Economic Security Act Relief Package Amount CoronavirusAidReliefAndEconomicSecurityActReliefPackageAmount	2000000000000	usd
CY2020Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	91035	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	710315	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1777000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	bomo	Gain On New Methodology For Accounting For Debt Conversion Features GainOnNewMethodologyForAccountingForDebtConversionFeatures		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2023	bomo	Reconciliation Of Debt Balances ReconciliationOfDebtBalances		usd
CY2023	bomo	Loss On Acquisition Related Party LossOnAcquisitionRelatedParty		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023	bomo	Gain On New Methodology For Accounting For Debt Conversion Features GainOnNewMethodologyForAccountingForDebtConversionFeatures		usd
CY2023	bomo	Forgiveness Of Note Payable Ppp Note ForgivenessOfNotePayablePPPNote		usd
CY2022	bomo	Forgiveness Of Note Payable Ppp Note ForgivenessOfNotePayablePPPNote		usd
CY2023	bomo	Grant Income GrantIncome		usd
CY2022	bomo	Grant Income GrantIncome		usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023	bomo	Cash Acquired In Reverse Merger CashAcquiredInReverseMerger		usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	bomo	Tangible Assets Acquired In Merger TangibleAssetsAcquiredInMerger		usd
CY2023	bomo	Equity Acquired In Merger Net Of Cancellation Of Shares EquityAcquiredInMergerNetOfCancellationOfShares		usd
CY2023	bomo	Debt Discount Associated With Issuance Of Warrants And Derivative Liabilities DebtDiscountAssociatedWithIssuanceOfWarrantsAndDerivativeLiabilities		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	bomo	Accrual For Shares To Be Issued For Acquisition Of Interview Mastery AccrualForSharesToBeIssuedForAcquisitionOfInterviewMastery		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	bomo	Gain On New Methodology For Accounting For Debt Conversion Features GainOnNewMethodologyForAccountingForDebtConversionFeatures		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001381871
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001213900-24-086614-index-headers.html	Edgar Link	pending
0001213900-24-086614-index.html	Edgar Link	pending
0001213900-24-086614.txt	Edgar Link	pending
0001213900-24-086614-xbrl.zip	Edgar Link	pending
bomo-20231231.xsd	Edgar Link	pending
ea0214383-10k_bowmo.htm	Edgar Link	pending
ea021438301ex31-1_bowmo.htm	Edgar Link	pending
ea021438301ex32-1_bowmo.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
bomo-20231231_lab.xml	Edgar Link	unprocessable
bomo-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0214383-10k_bowmo_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bomo-20231231_cal.xml	Edgar Link	unprocessable
bomo-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BOMO
bowmo, Inc. Stock $bomo

2024 Q4 Form 10-K Financial Statement

#000121390024086614 Filed on October 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOMO bowmo, Inc. Stock $bomo

2024 Q4 Form 10-K Financial Statement

#000121390024086614 Filed on October 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOMO
bowmo, Inc. Stock $bomo